Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19832806 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed 9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)
Condition: Bipolar Disorder
Interventions: Drug: Asenapine;   Drug: Olanzapine

Indicates status has not been verified in more than two years